Public Employees Retirement System of Ohio Makes New $1.44 Million Investment in Sotera Health Company $SHC

Public Employees Retirement System of Ohio purchased a new position in shares of Sotera Health Company (NASDAQ:SHC - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 81,132 shares of the company's stock, valued at approximately $1,440,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. IFP Advisors Inc lifted its stake in shares of Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company's stock valued at $26,000 after purchasing an additional 1,371 shares during the last quarter. Rothschild Investment LLC bought a new position in Sotera Health during the fourth quarter valued at about $27,000. Root Financial Partners LLC raised its holdings in Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company's stock valued at $30,000 after buying an additional 1,455 shares in the last quarter. Meeder Asset Management Inc. acquired a new stake in shares of Sotera Health in the second quarter worth about $37,000. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company's stock worth $37,000 after buying an additional 2,935 shares during the last quarter. Institutional investors own 91.03% of the company's stock.

Wall Street Analysts Forecast Growth

SHC has been the topic of a number of analyst reports. Citigroup increased their price objective on Sotera Health from $23.00 to $25.00 and gave the company a "buy" rating in a report on Friday, August 7th. UBS Group set a $19.00 target price on Sotera Health in a report on Wednesday, June 24th. JPMorgan Chase & Co. upped their target price on Sotera Health from $16.00 to $18.00 and gave the stock a "neutral" rating in a research report on Friday, August 7th. Piper Sandler reiterated an "overweight" rating and set a $25.00 price target (up from $22.00) on shares of Sotera Health in a report on Friday, August 7th. Finally, Wall Street Zen raised shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 29th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $21.50.

Insider Buying and Selling

In other Sotera Health news, insider Michael P. Rutz sold 150,000 shares of Sotera Health stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $18.84, for a total value of $2,826,000.00. Following the transaction, the insider directly owned 334,279 shares of the company's stock, valued at $6,297,816.36. The trade was a 30.97% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the company's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman owned 3,969,393 shares of the company's stock, valued at approximately $73,433,770.50. This trade represents a 17.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 1,294,515 shares of company stock worth $23,999,528 in the last ninety days. Insiders own 15.36% of the company's stock.

Sotera Health Price Performance

SHC stock opened at $18.90 on Tuesday. The stock has a market capitalization of $5.39 billion, a price-to-earnings ratio of 33.16 and a beta of 1.77. The company has a 50-day moving average of $18.38 and a two-hundred day moving average of $16.48. Sotera Health Company has a 52-week low of $13.09 and a 52-week high of $19.85. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The business had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. During the same period in the previous year, the company posted $0.20 earnings per share. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, equities research analysts anticipate that Sotera Health Company will post 0.86 EPS for the current year.

Sotera Health Profile

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.